TFF Pharmaceuticals, Inc. (TFFP)
USD 0.07
(-60.05%)
USD 0.07
(-60.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.03 Million | -27.34 Million | -29.55 Million | -16.61 Million | -11.21 Million | -2.12 Million |
| Net Income | -21.24 Million | -31.77 Million | -31.03 Million | -18.56 Million | -11.87 Million | -3.84 Million |
| Depreciation & Amortization | 502.48 Thousand | 388.22 Thousand | 111.45 Thousand | - | - | - |
| Deferred income taxes | -38.38 Thousand | -5.03 Million | -6.18 Million | - | - | - |
| Stock-based compensation | 2.92 Million | 4.25 Million | 3.54 Million | 2.18 Million | 590.04 Thousand | - |
| Change in working capital | 1.52 Million | -212.15 Thousand | -2.17 Million | -235.5 Thousand | 64.06 Thousand | 386.12 Thousand |
| Other non-cash items | 288.7 Thousand | 5.03 Million | 6.18 Million | 1.32 Million | 577.59 Thousand | 930.88 Thousand |
| Investing Cash Flow | -94.75 Thousand | -1.55 Million | -868.5 Thousand | -1.1 Million | - | - |
| Investments in PPE | -94.75 Thousand | -1.55 Million | -868.5 Thousand | -1.1 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 5.01 Million | 11.75 Million | 28.88 Million | 24.99 Million | 29.04 Million | 12.38 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | -875.35 Thousand | - |
| Common Stock Repurchased | -2875.00 | - | - | - | - | - |
| Common Stock Issuance | 5.01 Million | 404.55 Thousand | 28.88 Million | 24.28 Million | 21.85 Million | 12.38 Million |
| Other Financing Activities | -2875.00 | 11.34 Million | 869.96 Thousand | 714.38 Thousand | 8.07 Million | - |
| Accounts receivables | -259.79 Thousand | 567.13 Thousand | -2.62 Million | - | - | - |
| Accounts payables | 38.38 Thousand | -577.1 Thousand | 209.19 Thousand | 862.67 Thousand | 12.44 Thousand | 398.18 Thousand |
| Inventory | - | -567.13 Thousand | 2.62 Million | - | - | - |
| Other working capital | 1.74 Million | 364.95 Thousand | -2.38 Million | -1.09 Million | 51.61 Thousand | -12.06 Thousand |
| Cash at beginning of period | 16.61 Million | 33.79 Million | 35.3 Million | 28.09 Million | 10.26 Million | - |
| Cash at end of period | 5.47 Million | 16.61 Million | 33.79 Million | 35.3 Million | 28.09 Million | 10.26 Million |
| Capital Expenditure | -94.75 Thousand | -1.55 Million | -868.5 Thousand | -1.1 Million | - | - |
| Effect of forex changes on cash | -14.66 Thousand | -39.87 Thousand | 34.35 Thousand | -70.39 Thousand | - | - |
| Net cash flow / Change in cash | -11.13 Million | -17.18 Million | -1.5 Million | 7.2 Million | 17.83 Million | 10.26 Million |
| Free Cash Flow | -16.13 Million | -28.89 Million | -30.42 Million | -17.71 Million | -11.21 Million | -2.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.47 Million | -5.73 Million | -4.76 Million | -21.24 Million | -4.4 Million | -5.02 Million |
| Depreciation & Amortization | 140.59 Thousand | 140.18 Thousand | 130.66 Thousand | 502.48 Thousand | 125.11 Thousand | 123.52 Thousand |
| Deferred income taxes | - | - | -920.3 Thousand | -38.38 Thousand | - | - |
| Stock-based compensation | 608.35 Thousand | 626.99 Thousand | 582.43 Thousand | 2.92 Million | 766.31 Thousand | 825.71 Thousand |
| Change in working capital | -83.67 Thousand | 1.85 Million | 364.7 Thousand | 1.52 Million | 468.13 Thousand | -396.86 Thousand |
| Other non-cash items | 1.86 Million | 44.26 Thousand | 391.3 Thousand | 288.7 Thousand | 49 Thousand | 9692.00 |
| Investing Cash Flow | - | - | -46.39 Thousand | -94.75 Thousand | -12.65 Thousand | -35.7 Thousand |
| Investments in PPE | 1.00 | - | -46.39 Thousand | -94.75 Thousand | -12.65 Thousand | -35.7 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.42 Million | 901.13 Thousand | 567.00 | 5.01 Million | 5.08 Million | -59.22 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -2875.00 | - | - |
| Common Stock Issuance | 4.42 Million | 901.13 Thousand | 3442.00 | 5.01 Million | 5.08 Million | -59.22 Thousand |
| Other Financing Activities | -67.72 Thousand | -15 Thousand | -2875.00 | -2875.00 | - | -59.22 Thousand |
| Accounts receivables | -103.52 Thousand | 128.44 Thousand | -48.01 Thousand | -259.79 Thousand | -89.51 Thousand | -97.36 Thousand |
| Accounts payables | -307.13 Thousand | 707.42 Thousand | -28.52 Thousand | 38.38 Thousand | -21.59 Thousand | -338.24 Thousand |
| Inventory | - | - | -211.78 Thousand | - | 89.51 Thousand | 97.36 Thousand |
| Other working capital | 326.98 Thousand | 1.01 Million | 441.24 Thousand | 1.74 Million | 489.72 Thousand | -58.61 Thousand |
| Cash at beginning of period | 3.21 Million | 5.47 Million | 9.72 Million | 16.61 Million | 7.66 Million | 12.21 Million |
| Cash at end of period | 4.38 Million | 3.21 Million | 5.47 Million | 5.47 Million | 9.72 Million | 7.66 Million |
| Capital Expenditure | 1.00 | - | -46.39 Thousand | -94.75 Thousand | -12.65 Thousand | -35.7 Thousand |
| Effect of forex changes on cash | 4012.00 | -23.05 Thousand | 11.78 Thousand | -14.66 Thousand | -13.88 Thousand | -322.00 |
| Net cash flow / Change in cash | 1.17 Million | -2.26 Million | -4.24 Million | -11.13 Million | 2.06 Million | -4.55 Million |
| Free Cash Flow | -3.25 Million | -3.14 Million | -4.25 Million | -16.13 Million | -3.01 Million | -4.49 Million |
MGU
EPSN
0931
1414
0KUT
ANZ